Combination Therapies in Bladder Cancer: Insights and Challenges

4 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
In part four of this roundtable, Roger Li, MD, Vitaly Margulis, MD, Kyle Rose, MD, and Paul Crispen, MD, debate the potential of combining intravesical immunotherapy with immune checkpoint inhibitors and the evolving role of chemotherapy in BCG-unresponsive disease. The panelists provide insights on emerging data, treatment durability, and practical considerations like patient accessibility and cost, highlighting the complex decision-making landscape for high-risk non-muscle-invasive bladder cancer therapies.

#bladdercancer #bladdercancerawarenessmonth #oncology #cancer #healthcare #urology
Category
Oncology
Be the first to comment

Up Next